GEN-MKT-18-7897-A
Feb 17, 2016 | Blogs, Food / Beverage | 0 comments
During RAFA 2015, New Food Magazine hosted a roundtable (sponsored by SCIEX) to bring together experts with routine food testing backgrounds to discuss the latest industry trends, challenges, recent technological advances, and expectations of future laboratories.
Both Vincent Paez, Senior Director of Food Testing and Andre Schreiber, Technical Applications Manager from SCIEX were in attendance and contribute with their extensive experience of working with and supporting routine testing laboratories, as well as developing advanced workflows on the forefront of food safety.
The roundtable began with a simple question, “In the next 10 years what key changes do you see happening in the food and beverage industry in terms of food analysis?” A detailed discussion followed which covered the aspects of commercial laboratory testing, university laboratory research, the rise of digital technologies and the simplification of processes – in particular, the importance of informatics.
If you are interested in learning more about what each of the speakers had to say we have embedded the full 51-minute roundtable for you to watch below.
Be sure to leave a comment below and share your thoughts on the questions asked as part of the discussion, or raise any questions you would like to be included in future roundtables!
Also, if you’re interested in watching more from RAFA 2015, check out Andre’s seminar titled “Igniting Your Routine Testing Methods.”
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
At SCIEX, innovation doesn’t stop at instruments; it extends to how you interact with your LC-MS/MS or CE systems every day. That’s why we’re excited to introduce the SCIEX Now spring 2026 improvements: a set of meaningful enhancements shaped directly by your feedback.
Posted by
You must be logged in to post a comment.
Share this post with your network